Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Oncology Research|June 26, 2026
Engineering the Future of ADCs in Non-Small Cell Lung CancerMi Rim Kim, Jason Lau, Michele Maffezzoli, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|November 29, 2019
Relationship of transcutaneous oxygen tension with age and skin elasticity in Korean womenSuji Yoo, Mi-Rim Kim, Tae-Yoon Kim, et al.
Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion|November 15, 2019
[Observation on therapeutic effect of acupuncture at "experienced ten acupoints" for postprandial distress syndrome]Mi-Rim Kim, He-Wen Li, Jing-Wen Yang, et al.
Chinese Medicine|November 21, 2024
Acupuncture improves the symptoms, serum ghrelin, and autonomic nervous system of patients with postprandial distress syndrome: a randomized controlled trialZi-Tong Fu, Cun-Zhi Liu, Mi-Rim Kim, et al.
Journal of Clinical Medicine|March 28, 2026
The Current Landscape of Artificial Intelligence in Positron Emission Tomography (PET) Imaging Across the Cancer ContinuumWut Yee The Zar, Mi Rim Kim, Aruni Ghose, et al.
European Neurology|July 11, 2013
Effects of levetiracetam monotherapy on the cognitive function of epilepsy patientsDae Lim Koo, Kyoung Jin Hwang, Daeyoung Kim, et al.
Sleep|July 2, 2013
Brain Gray Matter Deficits in Patients with Chronic Primary InsomniaEun Yeon Joo, Hyun Jin Noh, Jeong-Sik Kim, et al.
Gastroenterology|March 7, 2021
Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel DiseaseStefan Schreiber, Shomron Ben-Horin, Jaroslaw Leszczyszyn, et al.
Open Forum Infectious Diseases|March 17, 2022
Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019Anca Streinu-Cercel, Oana Săndulescu, Liliana-Lucia Preotescu, et al.
Open Forum Infectious Diseases|August 31, 2022
A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019Jin Yong Kim, Oana Săndulescu, Liliana-Lucia Preotescu, et al.
Pageof 1